WACKER acquires plasmid DNA Manufacturer Genopis
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
EBITDA and PAT for the quarter were both up 11% to Rs. 193 crores and Rs. 102 crores respectively.
The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.
Novasep's viral vector business is an excellent strategic fit as Thermo Fisher continues to expand its capabilities for cell and gene vaccines and therapies globally," said Michel Lagarde, executive vice president, Thermo Fisher.
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Subscribe To Our Newsletter & Stay Updated